← Back to Clinical Trials
Recruiting NCT07701174

NCT07701174 Weighted Dangling Exercises vs Vastus Medialis Oblique Muscle Neuromuscular Stimulation for Knee Osteoarthritis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07701174
Status Recruiting
Phase
Sponsor University of Lahore
Condition Osteoarthritis
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2026-05-25
Primary Completion 2026-08-25

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Interventional group Ainterventional group B

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2026-05-25 with a primary completion date of 2026-08-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial aims to compare the effectiveness Weighted dangling exercises versus vastus medialis oblique muscle neuromuscular electrical stimulation(VMO+NMES) in patients with knee osteoarthritis. The study will recruit 48 participants (accounting for 10% attrition), aged 40-60 years, from University of Lahore Teaching Hospital using convenience sampling. Participants will be randomly allocated into two groups: an interventional group receiving WDE and other interventional group undergoing VMO strength training with NMES. Both interventions will be administered three times per week for 8 weeks under professional supervision. Outcome measures including pain intensity (NPRS), Functional Disability (Western Ontario and McMaster Universities Osteoarthritis Index),Muscle Strength (MMT) will be assessed at baseline, 4 weeks, and 8 weeks. Data will be analyzed using SPSS, with appropriate parametric or non-parametric tests applied after checking data normality. Ethical approval will be obtained, informed consent will be secured, and participant confidentiality will be strictly maintained.

Eligibility Criteria

Inclusion Criteria: Both genders and aged between 40 and 60 years. Symptoms of unilateral knee pain and crepitus persist for at least 6 months during ascending and descending motion. Radiographic KOA; grade 2 or more according to Kellgren and Lawrence scale. Patient referred by an orthopedic physician Those who have taken oral corticosteroids within the last month or who received intra-articular corticosteroid injection or analgesic injection intervention for hip or knee pain within the last 3 month Exclusion Criteria: * Recent surgery (within three months) history of hip or knee joint replacement, tibial osteotomy, orthoses with systemic arthritis, history of trauma such as knee fracture and other with muscular disease of neurological disorders that would affect lower extremity function is excluded.

Contact & Investigator

Central Contact

Ishaq Ahmed, PhD PT

✉ ishaq.ahmed@uipt.uol.edu.pk

📞 03344066463

Principal Investigator

Mahnoor Fatima, MS MSK*

PRINCIPAL INVESTIGATOR

University Institute of Physical Therapy, University of Lahore

Frequently Asked Questions

Who can join the NCT07701174 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07701174 currently recruiting?

Yes, NCT07701174 is actively recruiting participants. Contact the research team at ishaq.ahmed@uipt.uol.edu.pk for enrollment information.

Where is the NCT07701174 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07701174 clinical trial?

NCT07701174 is sponsored by University of Lahore. The principal investigator is Mahnoor Fatima, MS MSK* at University Institute of Physical Therapy, University of Lahore. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology